Late HIV diagnosis among immigrants in Spain vs. native-born Spaniards, 2010-15.


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
01 12 2021
Historique:
pubmed: 19 8 2021
medline: 3 2 2022
entrez: 18 8 2021
Statut: ppublish

Résumé

In 2012, the central government of Spain enacted Royal Decree-Law (RDL) 16/2012 and Royal Decree (RD) 1192/2012, which abolished universal healthcare coverage, thus limiting access to care for undocumented immigrants. Free health care was also no longer granted to anyone who has never been employed. In this context, this study investigated the prevalence of late HIV diagnoses (LHDs) among immigrants living in Spain vs. native-born Spaniards. Data (n = 5943) from the 2010 to 2015 Cohort of the Spanish AIDs Research Network were used, including HIV-positive and antiretroviral therapy (ART)-naïve patients throughout Spain. Multivariate logistic models were fitted to compare the prevalence of LHD among the groups, adjusting for covariates. The prevalence of LHD in the total sample was 39.5%. Compared with native-born Spaniards (n = 4445), immigrants (n = 1488) were more likely to have LHD (37.4% vs. 45.7%, respectively; P < 0.001). Multivariate analysis showed that the prevalence ratio of LHD among immigrants vs. native-born Spaniards was 1.15 [95% confidence interval (CI), 1.02-1.28], after adjusting for covariates. This disparity widened from 2010 to 2011 (APR = 1.14, 95% CI, 1.02-1.29) to 2012-15 (APR = 1.28, 95% CI, 1.17-1.39), although the change was not statistically significant. Immigrants in Spain had a higher risk of LHD compared with native-born counterparts. LHD is an important healthcare marker due to the positive benefits of early HIV diagnosis, including prevention, improvements in health outcomes and decreases in overall cost of treatment. More research is needed on the causes of the disparity and potential social and policy interventions to reduce the prevalence of LHD among immigrants.

Sections du résumé

BACKGROUND
In 2012, the central government of Spain enacted Royal Decree-Law (RDL) 16/2012 and Royal Decree (RD) 1192/2012, which abolished universal healthcare coverage, thus limiting access to care for undocumented immigrants. Free health care was also no longer granted to anyone who has never been employed. In this context, this study investigated the prevalence of late HIV diagnoses (LHDs) among immigrants living in Spain vs. native-born Spaniards.
METHODS
Data (n = 5943) from the 2010 to 2015 Cohort of the Spanish AIDs Research Network were used, including HIV-positive and antiretroviral therapy (ART)-naïve patients throughout Spain. Multivariate logistic models were fitted to compare the prevalence of LHD among the groups, adjusting for covariates.
RESULTS
The prevalence of LHD in the total sample was 39.5%. Compared with native-born Spaniards (n = 4445), immigrants (n = 1488) were more likely to have LHD (37.4% vs. 45.7%, respectively; P < 0.001). Multivariate analysis showed that the prevalence ratio of LHD among immigrants vs. native-born Spaniards was 1.15 [95% confidence interval (CI), 1.02-1.28], after adjusting for covariates. This disparity widened from 2010 to 2011 (APR = 1.14, 95% CI, 1.02-1.29) to 2012-15 (APR = 1.28, 95% CI, 1.17-1.39), although the change was not statistically significant.
CONCLUSIONS
Immigrants in Spain had a higher risk of LHD compared with native-born counterparts. LHD is an important healthcare marker due to the positive benefits of early HIV diagnosis, including prevention, improvements in health outcomes and decreases in overall cost of treatment. More research is needed on the causes of the disparity and potential social and policy interventions to reduce the prevalence of LHD among immigrants.

Identifiants

pubmed: 34405861
pii: 6354126
doi: 10.1093/eurpub/ckab089
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1123-1128

Subventions

Organisme : Health Institute of Carlos III
Organisme : Red Thematic Research Cooperative in AIDS
Organisme : Temática de Investigación Cooperativa en Sida
ID : RD06/006
Organisme : National Plan R + D + I
Organisme : ISCIII General Sub-direction for Evaluation and the European Regional Development Fund
Organisme : Health Institute of Carlos III through the Red Thematic Research Cooperative in AIDS
ID : RD06/006

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Auteurs

Megi Gogishvili (M)

Center for Systems and Community Design, CUNY Graduate School of Public Health & Health Policy, New York, NY, USA.

Terry T-K Huang (TT)

Center for Systems and Community Design, CUNY Graduate School of Public Health & Health Policy, New York, NY, USA.

Sergio A Costa (SA)

Center for Systems and Community Design, CUNY Graduate School of Public Health & Health Policy, New York, NY, USA.

Karen Florez (K)

Center for Systems and Community Design, CUNY Graduate School of Public Health & Health Policy, New York, NY, USA.

Pedro Mateu-Gelabert (P)

Institute for Implementation Science in Population Health, CUNY, New York, NY, USA.

Maria R A Valls (MRA)

University Hospital of Canary Islands, Santa Cruz de Tenerife, Spain.

María Rivero (M)

Navarra Hospital Complex, Navarra, Spain.

Maria Saumoy (M)

University of Bellvitge, Barcelona, Spain.

Gloria Samperiz (G)

University Hospital Miguel Servet, Aragon, Spain.

Miguel Cervero (M)

University Hospital Severo Ochoa, Madrid, Spain.

Federico Pulido (F)

University Hospital 12 de Octubre (IMAS12), Complutense University of Madrid (UCM), Madrid, Spain.

José A Pérez (JA)

Infectious Diseases Department, University Hospital Ramón y Cajal (IRYCIS), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH